Beam Therapeutics Inc. has grown revenue 25% a year over three years and 479% a year over five. Revenue growth, 3-year annual rate: +25% (Biotechnology median +21%). Revenue growth, 5-year rate: +479%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

BEAMBeam Therapeutics Inc.

HealthcareUSD

$30.17

$16.0152 weeks$35.53

Is it growing?

Is BEAM growing?

Beam Therapeutics Inc. has grown revenue 25% a year over three years and 479% a year over five.

+25%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +479%
Revenue growth, 5-year rate · +25% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›